Atalanta Therapeutics has bagged $97 million, money the biotech plans to use to launch clinical trials for its small ...

Morrison currently serves as CEO and as a member of the Board of Directors of Crossbow Therapeutics. TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers.

Dr. Morrison currently serves as Chief Executive Officer and as a member of the Board of Directors of Crossbow Therapeutics, Inc. He is trained as a medical oncologist with over 30 years of ...

taking place virtually Live webcasts of the Company’s presentations may be accessed under “News and Events” in the Investors section of the Dianthus Therapeutics website. Dianthus ...

A Green Country family is fighting to keep a killer behind bars. Jimmie Stohler is known as the “Crossbow Killer” and he’s up for parole on Monday, Jan. 13. He was convicted in connection ...

Leap Therapeutics, Inc. (NASDAQ:LPTX) released significant updates regarding its recent clinical findings and corporate presentation. In a press release titled “Leap Therapeutics Reports Initial ...

Outlook Therapeutics (OTLK) announced the presentation of data from NORSE EIGHT at the Hawaiian Eye and Retina 2025 Meeting being held January ...

with one poster selected for oral presentation by Dr. Eugen Mengel CELEBRATION, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a ...

In years past, crossbow manufacturers focused on increasing bolt speed while minimizing costs. Though speed is still a focal point for new crossbows, a few other trends emerged in 2025.